Varicella zoster virus vaccines: potential complications and possible improvements

scientific article published on 24 October 2014

Varicella zoster virus vaccines: potential complications and possible improvements is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1007135124
P356DOI10.1007/S12250-014-3516-9
P698PubMed publication ID25358998

P2093author name stringHua Zhu
Benjamin Silver
P2860cites workThe incidence of varicella and herpes zoster in Massachusetts as measured by the Behavioral Risk Factor Surveillance System (BRFSS) during a period of increasing varicella vaccine coverage, 1998-2003Q21257242
Acyclovir for treating varicella in otherwise healthy children and adolescentsQ24245470
Simple and highly efficient BAC recombineering using galK selectionQ24794075
Changing Dynamics of Varicella‐Zoster Virus Infections in the 21st Century: The Impact of VaccinationQ28315860
Genome-wide mutagenesis reveals that ORF7 is a novel VZV skin-tropic factorQ28474768
Varicella-zoster virus immune evasionQ33683365
Neurologic complications of the reactivation of varicella-zoster virusQ33852905
Advances in in vivo bioluminescence imaging of gene expressionQ34138770
Herpes zoster incidence among insured persons in the United States, 1993-2006: evaluation of impact of varicella vaccinationQ34158156
Herpesvirus BACs: past, present, and futureQ34247863
Biological diversity, chemical mechanisms, and the evolutionary origins of bioluminescent systemsQ34257041
The impact of herpes zoster and postherpetic neuralgia on health-related quality of life: a prospective studyQ34273914
Varicella-zoster virus: molecular virology and virus-host interactionsQ34331560
Herpes simplex virus type 1 accumulation, envelopment, and exit in growth cones and varicosities in mid-distal regions of axonsQ34545675
Foscarnet salvage therapy for acyclovir-resistant varicella zoster: report of a novel thymidine kinase mutation and review of the literatureQ34586519
Rapid and quantitative assessment of cancer treatment response using in vivo bioluminescence imagingQ34786078
Construction of varicella-zoster virus recombinants from parent Oka cosmids and demonstration that ORF65 protein is dispensable for infection of human skin and T cells in the SCID-hu mouse modelQ34977139
Membrane fusion mediated by herpesvirus glycoproteins: the paradigm of varicella-zoster virusQ35159928
Varicella zoster virus infections in children after the introduction of live attenuated varicella vaccineQ35646762
In vivo bioluminescence imaging for integrated studies of infectionQ35685815
Herpes zoster virus infection.Q35937881
Generation of varicella-zoster virus (VZV) and viral mutants from cosmid DNAs: VZV thymidylate synthetase is not essential for replication in vitroQ36465730
Varicella-zoster vaccine for the prevention of herpes zosterQ36773272
VZV infection of keratinocytes: production of cell-free infectious virions in vivoQ37708084
Varicella-zoster virus neurotropism in SCID mouse-human dorsal root ganglia xenograftsQ37708087
Investigation of varicella-zoster virus neurotropism and neurovirulence using SCID mouse-human DRG xenograftsQ37967565
Visualizing gene expression in living mammals using a bioluminescent reporter.Q38555717
Real-time analysis of the transcriptional regulation of HIV and hCMV promoters in single mammalian cellsQ38572878
A highly efficient protocol of generating and analyzing VZV ORF deletion mutants based on a newly developed luciferase VZV BAC systemQ40021337
Genetic analysis of varicella-zoster virus ORF0 to ORF4 by use of a novel luciferase bacterial artificial chromosome systemQ40117236
The Epidemiology of Varicella and Its ComplicationsQ40473009
Aspects of the host response to varicella-zoster virus: a review of recent observationsQ40936753
Mechanisms of varicella-zoster virus neuropathogenesis in human dorsal root gangliaQ42117334
Use of recombination-mediated genetic engineering for construction of rescue human cytomegalovirus bacterial artificial chromosome clonesQ42257417
Reduction of liver Fas expression by an antisense oligonucleotide protects mice from fulminant hepatitisQ43505905
Varicella-zoster virus in children immunized with the varicella vaccineQ43521755
Valproic acid enhances gene expression from viral gene transfer vectorsQ45287153
Cloning of the varicella-zoster virus genome as an infectious bacterial artificial chromosome in Escherichia coliQ45589357
Herpes zoster by reactivated vaccine varicella zoster virus in a healthy childQ45731390
Circadian regulation of a viral gene promoter in live transgenic mice expressing firefly luciferase.Q50749927
Bioluminescence emission from the reaction of luciferase-flavin mononucleotide radical with O2-..Q50929600
Herpes zoster and quality of life: a self-limited disease with severe impact.Q53635133
Zoster in the elderly: clinical, immunologic and therapeutic considerationsQ72402547
DNA cloning by homologous recombination in Escherichia coliQ73256761
Herpes zoster and postherpetic neuralgia: incidence and risk indicators using a general practice research databaseQ78304911
Development of a gene capture method to rescue a large deletion mutant of human cytomegalovirusQ83222849
P433issue5
P304page(s)265-273
P577publication date2014-10-24
P1433published inVirologica SinicaQ26841812
P1476titleVaricella zoster virus vaccines: potential complications and possible improvements
P478volume29

Reverse relations

cites work (P2860)
Q37158220Efficacy of varicella (VZV) vaccination: an update for the clinician
Q89738329Pediatric Herpes Zoster
Q47242634Post-herpetic neuralgia - a review of current management and future directions

Search more.